Drug shortage
Barium Sulfate Suspension · Bracco Diagnostics
FDA drug shortage · To Be Discontinued · updated May 2, 2024
Key facts
| Generic name | Barium Sulfate Suspension |
|---|---|
| Proprietary name | Liquid Polibar Plus |
| Company | Bracco Diagnostics |
| Presentation | Liquid Polibar Plus, Suspension, 1.05 g/1 mL (NDC 32909-167-55) |
| Dosage form | Suspension |
| Strength | 1.05 g/1 mL |
| Status | To Be Discontinued |
| Therapeutic category | Medical Imaging |
| Package NDCs | 32909-167-55 |
| First posted | May 2, 2024 |
| Last updated | May 2, 2024 |
| Discontinued | May 2, 2024 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: